For women living with obesity or weight-related health conditions, this approval represents an important expansion of treatment choice and reflects the continued evolution of obesity care
A non-smoker, or willing to quit before and after surgery
Top GLP-1 Legal & Regulatory Concerns for Investors Miranda Schmalfuhs In this part of his Pharmaceutical Executive video interview, Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses the top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
While researchers may legally purchase TB-500 as a reference material, it is nonetheless prudent to check local laws before placing an order
When a compound is used across several readout families, the value of a consistent dispensing format and documented specifications increases because it helps laboratories attribute differences to experimental variables rather than preparation drift